TLDR: AVANT BIO, an early-stage and growth equity firm, along with its portfolio company Intrepid Labs, have both received nominations for the prestigious Prix Galien USA Awards. AVANT BIO is recognized in the ‘Incubators, Accelerators and Equity’ category, while Intrepid Labs, known for its application of artificial intelligence and robotics in drug development, is nominated for ‘Best Start Up’.
NEW YORK – August 13, 2025 – AVANT BIO, a pioneering early-stage and growth equity firm, and its innovative portfolio company, Intrepid Labs, have garnered significant recognition with nominations for the highly esteemed Prix Galien USA Awards. This dual nomination highlights AVANT BIO’s strategic investment philosophy and Intrepid Labs’ groundbreaking advancements in the life sciences sector.
AVANT BIO has been nominated in the ‘Incubators, Accelerators and Equity’ category, acknowledging its role in fostering high-impact companies that merge cutting-edge technologies with a deeper understanding of biology. Intrepid Labs, a recent investment by AVANT BIO, has secured a nomination in the highly competitive ‘Best Start Up’ category.
Daniella Kranjac, Founding GP of AVANT BIO, expressed her enthusiasm regarding the nominations. ‘This recognition underscores the value and impact of our investment focus. To be acknowledged alongside such distinguished companies in the industry is both humbling and inspiring,’ she stated. Kranjac further emphasized the significance of Intrepid Labs’ nomination, noting, ‘We are also thrilled that our most recent investment, Intrepid Labs, has been nominated in the extremely competitive start-up category. Their use of artificial intelligence (AI) and robotics is transforming drug formulation development through effective formulations that improve clinical performance.’
The Prix Galien Awards, established in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology, are globally regarded as the equivalent of the Nobel Prize in biopharmaceutical research. The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, oversees these annual awards.
Also Read:
- Startup Daily Unveils 2025 Best in Tech Awards Finalists, Highlighting Innovation Across 14 Categories
- Leading Innovators Honored: The 2025 SaaS Awards Announce Winners
For the 2025 Prix Galien USA edition, AVANT BIO stands among 12 nominees in its category, while Intrepid Labs was selected from a robust field of 55 companies. Both companies are slated to participate in the Galien Forum business meetings and the Galien Awards Gala, which will take place on October 30, 2025, at the American Museum of Natural History in New York City. This event will bring together industry experts and key stakeholders from the U.S. healthcare sector, celebrating innovation that propels healthcare forward.
